Purchase Order HHSD2002016M88469P
- Not listed
- This $95,000.00 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Bio-Rad Laboratories, Inc. Life Science Group Division for LABORATORY SUPPLIES. The contract has no set-aside designation. Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostics equipment, reagents, and consumables. It has established relationships with multiple federal agencies, including the CDC, through prime contract...
- This is a $124,117.10 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Bio Rad Laboratories Inc., a global manufacturer of life science research and clinical diagnostic products. The contract is for the supply of unspecified products and services, and does not have a set-aside designation. Bio Rad Laboratories Inc. is a subsidiary of the parent company Bio-Rad Laboratories, Inc., which serves as a prime contractor on numerous federal...
- This is a $24,995.00 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the parent company Bio-Rad Laboratories, Inc. The contract does not have a set-aside designation. The award is for the provision of unspecified products and services related to Bio-Rad's capabilities in providing laboratory equipment, reagents, and consumables for biomedical research and clinical...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $82,742.00 firm fixed-price purchase order contract to Bio-Rad Laboratories, Inc. Life Science Group Division for the provision of laboratory supplies. The contract has an ultimate completion date of September 21, 2024. Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostic products. As the parent company, Bio-Rad Laboratories, Inc. holds several significant federal Indefinite Delivery...
- This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Bio-Rad Laboratories, Inc. Life Science Group Division, a for-profit manufacturer of biotechnology products and laboratory equipment. The $103,398.60 firm-fixed-price purchase order is for the delivery of a DDPCR SYSTEM. No set-aside designation was indicated. Bio-Rad Laboratories holds a 5-year, $1 billion blanket purchase agreement with the National Institutes of...
- This firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Bio-Rad Laboratories, Inc. for annual service to maintain, calibrate, and repair laboratory equipment manufactured by Bio-Rad that is used to conduct and analyze HIV prevention and transmission scientific studies. The contract is valued at $135,768.00 and runs through June 30, 2025. No set-aside designation was used for this sole source procurement, which was authorized under FAR...
- This is a $137,410.00 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Bio-Rad Laboratories, Inc. Life Science Group Division for bio-rad maintenance and repair services. The contract has an ultimate completion date of August 18, 2029. Bio-Rad Laboratories, Inc. is the parent company of the awardee, a global leader in developing and manufacturing products for life science research and clinical diagnostics. The award does not utilize any set-aside...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Bio Rad Laboratories Inc., a global manufacturer of life science research and clinical diagnostic products. The $91,200 contract is for the supply of HIV diagnostic assays, with a completion date of December 28, 2017. Bio Rad Laboratories, operating as Bio-Rad Laboratories, Inc., has secured numerous federal contracts from agencies such as the Department of Veterans Affairs, Department of...
- This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Bio-Rad Laboratories, Inc., a global leader in developing and manufacturing products for life science research and clinical diagnostics. The $88,935.00 contract is for the provision of Bio-Rad reagents, with an ultimate completion date of September 25, 2020. The contract was a Blanket Purchase Agreement (BPA) call with a firm fixed-price pricing type. Bio-Rad Laboratories, Inc. has established several...
- Bio-Rad Laboratories Inc. was awarded a $33,000 firm fixed-price purchase order by the Centers for Disease Control and Prevention (CDC) Pittsburgh on August 14, 2024, for FDA-approved test kits, readers, and laptops designed to strengthen rapid test quality assurance internationally. The contract, which carries an ultimate completion date of April 22, 2025, represents an unrestricted procurement with no small business set-aside designation. Performance will be executed at Bio-Rad's Hercules,...
This is a firm fixed price purchase order for $154,275.00 awarded by the Centers for Disease Control and Prevention (CDC) to Bio-Rad Laboratories, Inc. Life Science Group Division for the "Generation and Production Human Fab" requirement. The contract has no set-aside designation. Bio-Rad Laboratories, Inc. is the prime contractor and the parent organization. The contract likely supports the CDC's biomedical research and testing activities through the provision of various life science research products and services, such as real-time PCR systems, thermal cyclers, and reagent kits. Bio-Rad Laboratories, Inc. holds a major $1 billion Blanket Purchase Agreement with the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations, which facilitates the efficient procurement of biological materials, laboratory supplies, and other items across NIH research programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 3 | Other Administrative Action | $0 | 7/18/22 | |
| 2 | Exercise an Option | $34.5k | 12/16/16 | |
| 1 | Other Administrative Action | $0 | 5/27/16 | |
| Not listed | Not listed | $31.2k | 12/1/15 |